Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

被引：0
|
作者：
Danni Li
Fangying Huang
Yingchun Zhao
Peter W. Villata
Timothy J. Griffin
Lin Zhang
Ling Li
Fang Yu
机构：
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Masonic Cancer Center
[3] University of Minnesota,Department of Biochemistry, Molecular Biology, and Biophysics
[4] University of Minnesota,Department of Biostatistics
[5] University of Minnesota,Department of Experimental and Clinical Pharmacology
[6] University of Minnesota,School of Nursing
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Alzheimer’s disease; Plasma lipoproteins; Targeted proteomics; Complement C3; Very low-density lipoprotein (VLDL); Intermediate density lipoprotein (IDL); Low density lipoprotein (LDL); High-density lipoprotein (HDL); Biomarker; Diagnosis; Selected reaction monitoring (SRM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study
    Liebert, Ann
    Bicknell, Brian
    Laakso, E-Liisa
    Heller, Gillian
    Jalilitabaei, Parastoo
    Tilley, Sharon
    Mitrofanis, John
    Kiat, Hosen
    BMC NEUROLOGY, 2021, 21 (01)
  • [32] Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study
    Ann Liebert
    Brian Bicknell
    E-Liisa Laakso
    Gillian Heller
    Parastoo Jalilitabaei
    Sharon Tilley
    John Mitrofanis
    Hosen Kiat
    BMC Neurology, 21
  • [33] Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study
    Simone Rossi
    Tommaso Lisini Baldi
    Marco Aggravi
    Monica Ulivelli
    David Cioncoloni
    Viola Niccolini
    Lorenzo Donati
    Domenico Prattichizzo
    Neurological Sciences, 2020, 41 : 3643 - 3651
  • [34] Wearable haptic anklets for gait and freezing improvement in Parkinson's disease: a proof-of-concept study
    Rossi, Simone
    Baldi, Tommaso Lisini
    Aggravi, Marco
    Ulivelli, Monica
    Cioncoloni, David
    Niccolini, Viola
    Donati, Lorenzo
    Prattichizzo, Domenico
    NEUROLOGICAL SCIENCES, 2020, 41 (12) : 3643 - 3651
  • [35] Prediagnostic expressions in health records predict mortality in Parkinson's disease: A proof-of-concept study
    Kuusimaki, Tomi
    Sainio, Jani
    Kurki, Samu
    Vahlberg, Tero
    Kaasinen, Valtteri
    PARKINSONISM & RELATED DISORDERS, 2022, 95 : 35 - 39
  • [36] Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
    Cummings, Jeffrey L.
    Zhong, Kate
    Kinney, Jefferson W.
    Heaney, Chelcie
    Moll-Tudla, Joanne
    Joshi, Abhinay
    Pontecorvo, Michael
    Devous, Michael
    Tang, Anne
    Bena, James
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [37] Degradation of Tattoo Inks by Cold Atmospheric Plasma Treatment: A Proof-of-Concept Study
    Çukur E.
    Ercan U.K.
    Plasma Medicine, 2022, 12 (03) : 1 - 21
  • [38] HARBOR: ABBV-916 In Subjects With Early Alzheimer's Disease Combined Multiple-Ascending Dose/Proof-Of-Concept Study Design
    Watson, David
    Lynch, Shau Yu
    Florian, Hana
    Wang, Deli
    Bachhav, Sagar
    Boiser, Joey
    Bannon, Anthony
    Stage, Edwin
    Graff, Ole
    NEUROLOGY, 2023, 100 (17)
  • [39] Validity of plasma collection cards for ferritin assessment-A proof-of-concept study
    Koehler, Karsten
    Marks-Nelson, Eileen
    Braga, Camila P.
    Beckford, Safiya
    Adamec, Jiri
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (06) : 554 - 561
  • [40] Simpson’s paradox in proof-of-concept studies
    Sok-Ja Janket
    Leland K Ackerson
    Eleftherios Diamandis
    Nature Medicine, 2019, 25 : 1640 - 1640
12345